Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Atea Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- −2 vs. Q1 2026
- Shares held
- 59.4M
- −660.9K (−1.1%) vs. Q1 2026
- Total value
- $276.4M
- −$46.4M (−14.4%) vs. Q1 2026
- New holders
- 18
- 46 more added
- Sold out
- 20
- 38 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Pictet & Cie SA | 345,077 | $1.60M | 0.02% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 345,186 | $1.61M | 0.00% | −34,128−9.0% | Reduced |
| Barclays PLC | 348,653 | $1.62M | 0.00% | +187,707+116.6% | Added |
| CM Management, LLC | 355,000 | $1.65M | 1.05% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 469,801 | $2.18M | 0.00% | −14,904−3.1% | Reduced |
| Goldman Sachs Group Inc | 530,856 | $2.47M | 0.00% | −57,607−9.8% | Reduced |
| Charles Schwab Investment Management Inc | 610,607 | $2.84M | 0.00% | +13,898+2.3% | Added |
| Vanguard Portfolio Management LLC | 630,185 | $2.93M | 0.00% | +72,606+13.0% | Added |
| Morgan Stanley | 719,514 | $3.35M | 0.00% | −11,506−1.6% | Reduced |
| Northern Trust Corp | 755,239 | $3.51M | 0.00% | +170,214+29.1% | Added |
| JPMorgan Chase & Co | 945,918 | $4.36M | 0.00% | +5,761+0.6% | Added |
| Rosalind Advisors, Inc. | 1,070,550 | $4.98M | 1.87% | −101,305−8.6% | Reduced |
| Renaissance Technologies LLC | 1,131,200 | $5.26M | 0.01% | −35,200−3.0% | Reduced |
| Dimensional Fund Advisors LP | 1,299,515 | $6.04M | 0.00% | +44,031+3.5% | Added |
| Two Sigma Investments, LP | 1,506,697 | $7.01M | 0.01% | −357,467−19.2% | Reduced |
| State Street Corp | 1,652,399 | $7.68M | 0.00% | −42,236−2.5% | Reduced |
| Geode Capital Management, LLC | 1,958,435 | $9.11M | 0.00% | +210,729+12.1% | Added |
| Acadian Asset Management LLC | 2,035,192 | $9.46M | 0.01% | +452,375+28.6% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,075,639 | $9.65M | 0.57% | −284,999−12.1% | Reduced |
| Vanguard Capital Management LLC | 2,964,862 | $13.8M | 0.00% | −281,262−8.7% | Reduced |
| Tang Capital Management LLC | 4,814,700 | $22.4M | 1.02% | 00.0% | Unchanged |
| BML Capital Management, LLC | 6,952,330 | $32.3M | 18.46% | −106,327−1.5% | Reduced |
| BlackRock, Inc. | 8,720,077 | $40.5M | 0.00% | +284,640+3.4% | Added |
| FMR LLC | 12,004,064 | $55.8M | 0.00% | +53,292+0.4% | Added |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −418,296−100.0% | Sold out |
| Irenic Capital Management LP | 0 | $0 | 0.00% | −301,699−100.0% | Sold out |
| Peapod Lane Capital LLC | 0 | $0 | 0.00% | −272,820−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −119,553−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −112,866−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −64,862−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −49,469−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −43,104−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −34,030−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −23,141−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −18,181−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −12,985−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,131−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −11,464−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −670−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −143−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −132−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −64−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |